rudolfomycin

structure in third source

Also Known As:

rudolphomycin; (1R-(1 alpha,2 beta,4 beta(2R*,6S*)))-4-((4-O-(4- O-(3-amino-5,6-dihydro-6-methyl-5-oxo-2H-pyran-2- yl)-2,6-dideoxy-alpha-L-lyxo-hexopyranosyl)-2,3,6-trideoxy-3-(dimethylamino)-alpha-L-lyxo-hexopyran osyl)oxy)-2-ethyl-1,2,3,4,6,11-hexahydro-2,5,7,10- tetrahydroxy-6,11-dioxo-1-naphthacenecarboxylic acid, methyl ester

Networked: 1 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Related Diseases

1.	Neoplasms (Cancer) 09/01/1980 - "The class II anthracycline antitumor antibiotics musettamycin, rudolfomycin, aclacinomycin and marcellomycin, which were shown in earlier studies to preferentially inhibit the synthesis of nucleolar RNA in intact tumor cells, were studied in an isolated nucleolar transcriptional assay. "

Related Drugs and Biologics

1.	Anthracyclines
2.	RNA (Ribonucleic Acid)
3.	Anti-Bacterial Agents (Antibiotics)
4.	musettamycin
5.	marcellomycin
6.	aclacinomycins

HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Application Error

An application error has occurred and our support engineers have been notified.

Please use the browser "Back" button and try your operation again.

OR if the error persists and you require an email response
please contact us at "cs at curehunter.com":

Your request
The circumstances of the error
Your login id/nickname or email

Return to Top Page